載入...
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults
BACKGROUND: This phase I trial evaluated the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime-MVA85A boost, previously demonstrated to be protective in animal studies, in healthy UK adults. METHODS: We enrolled 42 healthy, BCG-vaccinated adults into 4 grou...
Na minha lista:
| 發表在: | Vaccine |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier Science
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985898/ https://ncbi.nlm.nih.gov/pubmed/31735500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.10.102 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|